July 13, 2023 02:01 PM EDTUpdated 02:56 PM
R&D
Pharma
Marketing

Pfiz­er clin­i­cal tri­al reg­istry aims to re­cruit one mil­lion peo­ple for re­search

Beth Snyder Bulik

Senior Editor

Pfiz­er is look­ing to en­roll one mil­lion peo­ple for its new clin­i­cal tri­al reg­istry called Pfiz­er­Link. The bio­phar­ma is ad­ver­tis­ing the clin­i­cal tri­al con­nec­tor on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times